Cargando…
Cardiac magnetic resonance imaging versus computed tomography to guide transcatheter aortic valve replacement: study protocol for a randomized trial (TAVR-CMR)
BACKGROUND: The standard procedure for the planning of transcatheter aortic valve replacement (TAVR) is the combination of echocardiography, coronary angiography, and cardiovascular computed tomography (TAVR-CT) for the exact determination of the aortic valve dimensions, valve size, and implantation...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438296/ https://www.ncbi.nlm.nih.gov/pubmed/36056444 http://dx.doi.org/10.1186/s13063-022-06638-6 |
_version_ | 1784781797819678720 |
---|---|
author | Klug, Gert Reinstadler, Sebastian Troger, Felix Holzknecht, Magdalena Reindl, Martin Tiller, Christina Lechner, Ivan Fink, Priscilla Pamminger, Mathias Kremser, Christian Ulmer, Hanno Bauer, Axel Metzler, Bernhard Mayr, Agnes |
author_facet | Klug, Gert Reinstadler, Sebastian Troger, Felix Holzknecht, Magdalena Reindl, Martin Tiller, Christina Lechner, Ivan Fink, Priscilla Pamminger, Mathias Kremser, Christian Ulmer, Hanno Bauer, Axel Metzler, Bernhard Mayr, Agnes |
author_sort | Klug, Gert |
collection | PubMed |
description | BACKGROUND: The standard procedure for the planning of transcatheter aortic valve replacement (TAVR) is the combination of echocardiography, coronary angiography, and cardiovascular computed tomography (TAVR-CT) for the exact determination of the aortic valve dimensions, valve size, and implantation route. However, up to 80% of the patients undergoing TAVR suffer from chronic renal insufficiency. Alternatives to reduce the need for iodinated contrast agents are desirable. Cardiac magnetic resonance (CMR) imaging recently has emerged as such an alternative. Therefore, we aim to investigate, for the first time, the non-inferiority of TAVR-CMR to TAVR-CT regarding efficacy and safety end-points. METHODS: This is a prospective, randomized, open-label trial. It is planned to include 250 patients with symptomatic severe aortic stenosis scheduled for TAVR based on a local heart-team decision. Patients will be randomized in a 1:1 fashion to receive a predefined TAVR-CMR protocol or to receive a standard TAVR-CT protocol within 2 weeks after inclusion. Follow-up will be performed at hospital discharge after TAVR and after 1 and 2 years. The primary efficacy outcome is device implantation success at discharge. The secondary endpoints are a combined safety endpoint and a combined clinical efficacy endpoint at baseline and at 1 and 2 years, as well as a comparison of imaging procedure related variables. Endpoint definitions are based on the updated 2012 VARC-2 consensus document. DISCUSSION: TAVR-CMR might be an alternative to TAVR-CT for planning a TAVR procedure. If proven to be effective and safe, a broader application of TAVR-CMR might reduce the incidence of acute kidney injury after TAVR and thus improve outcomes. TRIAL REGISTRATION: The trial is registered at ClinicalTrials.gov (NCT03831087). The results will be disseminated at scientific meetings and publication in peer-reviewed journals. |
format | Online Article Text |
id | pubmed-9438296 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-94382962022-09-03 Cardiac magnetic resonance imaging versus computed tomography to guide transcatheter aortic valve replacement: study protocol for a randomized trial (TAVR-CMR) Klug, Gert Reinstadler, Sebastian Troger, Felix Holzknecht, Magdalena Reindl, Martin Tiller, Christina Lechner, Ivan Fink, Priscilla Pamminger, Mathias Kremser, Christian Ulmer, Hanno Bauer, Axel Metzler, Bernhard Mayr, Agnes Trials Study Protocol BACKGROUND: The standard procedure for the planning of transcatheter aortic valve replacement (TAVR) is the combination of echocardiography, coronary angiography, and cardiovascular computed tomography (TAVR-CT) for the exact determination of the aortic valve dimensions, valve size, and implantation route. However, up to 80% of the patients undergoing TAVR suffer from chronic renal insufficiency. Alternatives to reduce the need for iodinated contrast agents are desirable. Cardiac magnetic resonance (CMR) imaging recently has emerged as such an alternative. Therefore, we aim to investigate, for the first time, the non-inferiority of TAVR-CMR to TAVR-CT regarding efficacy and safety end-points. METHODS: This is a prospective, randomized, open-label trial. It is planned to include 250 patients with symptomatic severe aortic stenosis scheduled for TAVR based on a local heart-team decision. Patients will be randomized in a 1:1 fashion to receive a predefined TAVR-CMR protocol or to receive a standard TAVR-CT protocol within 2 weeks after inclusion. Follow-up will be performed at hospital discharge after TAVR and after 1 and 2 years. The primary efficacy outcome is device implantation success at discharge. The secondary endpoints are a combined safety endpoint and a combined clinical efficacy endpoint at baseline and at 1 and 2 years, as well as a comparison of imaging procedure related variables. Endpoint definitions are based on the updated 2012 VARC-2 consensus document. DISCUSSION: TAVR-CMR might be an alternative to TAVR-CT for planning a TAVR procedure. If proven to be effective and safe, a broader application of TAVR-CMR might reduce the incidence of acute kidney injury after TAVR and thus improve outcomes. TRIAL REGISTRATION: The trial is registered at ClinicalTrials.gov (NCT03831087). The results will be disseminated at scientific meetings and publication in peer-reviewed journals. BioMed Central 2022-09-02 /pmc/articles/PMC9438296/ /pubmed/36056444 http://dx.doi.org/10.1186/s13063-022-06638-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Study Protocol Klug, Gert Reinstadler, Sebastian Troger, Felix Holzknecht, Magdalena Reindl, Martin Tiller, Christina Lechner, Ivan Fink, Priscilla Pamminger, Mathias Kremser, Christian Ulmer, Hanno Bauer, Axel Metzler, Bernhard Mayr, Agnes Cardiac magnetic resonance imaging versus computed tomography to guide transcatheter aortic valve replacement: study protocol for a randomized trial (TAVR-CMR) |
title | Cardiac magnetic resonance imaging versus computed tomography to guide transcatheter aortic valve replacement: study protocol for a randomized trial (TAVR-CMR) |
title_full | Cardiac magnetic resonance imaging versus computed tomography to guide transcatheter aortic valve replacement: study protocol for a randomized trial (TAVR-CMR) |
title_fullStr | Cardiac magnetic resonance imaging versus computed tomography to guide transcatheter aortic valve replacement: study protocol for a randomized trial (TAVR-CMR) |
title_full_unstemmed | Cardiac magnetic resonance imaging versus computed tomography to guide transcatheter aortic valve replacement: study protocol for a randomized trial (TAVR-CMR) |
title_short | Cardiac magnetic resonance imaging versus computed tomography to guide transcatheter aortic valve replacement: study protocol for a randomized trial (TAVR-CMR) |
title_sort | cardiac magnetic resonance imaging versus computed tomography to guide transcatheter aortic valve replacement: study protocol for a randomized trial (tavr-cmr) |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438296/ https://www.ncbi.nlm.nih.gov/pubmed/36056444 http://dx.doi.org/10.1186/s13063-022-06638-6 |
work_keys_str_mv | AT kluggert cardiacmagneticresonanceimagingversuscomputedtomographytoguidetranscatheteraorticvalvereplacementstudyprotocolforarandomizedtrialtavrcmr AT reinstadlersebastian cardiacmagneticresonanceimagingversuscomputedtomographytoguidetranscatheteraorticvalvereplacementstudyprotocolforarandomizedtrialtavrcmr AT trogerfelix cardiacmagneticresonanceimagingversuscomputedtomographytoguidetranscatheteraorticvalvereplacementstudyprotocolforarandomizedtrialtavrcmr AT holzknechtmagdalena cardiacmagneticresonanceimagingversuscomputedtomographytoguidetranscatheteraorticvalvereplacementstudyprotocolforarandomizedtrialtavrcmr AT reindlmartin cardiacmagneticresonanceimagingversuscomputedtomographytoguidetranscatheteraorticvalvereplacementstudyprotocolforarandomizedtrialtavrcmr AT tillerchristina cardiacmagneticresonanceimagingversuscomputedtomographytoguidetranscatheteraorticvalvereplacementstudyprotocolforarandomizedtrialtavrcmr AT lechnerivan cardiacmagneticresonanceimagingversuscomputedtomographytoguidetranscatheteraorticvalvereplacementstudyprotocolforarandomizedtrialtavrcmr AT finkpriscilla cardiacmagneticresonanceimagingversuscomputedtomographytoguidetranscatheteraorticvalvereplacementstudyprotocolforarandomizedtrialtavrcmr AT pammingermathias cardiacmagneticresonanceimagingversuscomputedtomographytoguidetranscatheteraorticvalvereplacementstudyprotocolforarandomizedtrialtavrcmr AT kremserchristian cardiacmagneticresonanceimagingversuscomputedtomographytoguidetranscatheteraorticvalvereplacementstudyprotocolforarandomizedtrialtavrcmr AT ulmerhanno cardiacmagneticresonanceimagingversuscomputedtomographytoguidetranscatheteraorticvalvereplacementstudyprotocolforarandomizedtrialtavrcmr AT baueraxel cardiacmagneticresonanceimagingversuscomputedtomographytoguidetranscatheteraorticvalvereplacementstudyprotocolforarandomizedtrialtavrcmr AT metzlerbernhard cardiacmagneticresonanceimagingversuscomputedtomographytoguidetranscatheteraorticvalvereplacementstudyprotocolforarandomizedtrialtavrcmr AT mayragnes cardiacmagneticresonanceimagingversuscomputedtomographytoguidetranscatheteraorticvalvereplacementstudyprotocolforarandomizedtrialtavrcmr |